OxySure Therapeutics (OXYS) Launches New Cardiac Safety e-Commerce Website
Frisco, Texas, USA, March 8, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced the launch a new cardiac safety e-commerce retail website.
The website is located at www.AED-Oxygen.com and allows for the quick and easy purchase and checkout of Automated External Defibrillators (AEDs), OxySure emergency oxygen devices and all related accessories and supplies.
“Our customers, partners and stakeholders have spoken, and we have listened,” stated Julian Ross, CEO of OxySure. “There has been a steady call for a website that offers a way for retail customers to buy our innovative and lifesaving products from a website that is simple, easy to navigate and quick to check out. We are excited about AED-Oxygen.com and we plan to drive enormous amounts of traffic to this site.”
AED-Oxygen offers all the major AED brands, including Philips, Cardiac Science, Physio Control, Defibtech, and HeartSine. Customers can also easily buy accessories for these AEDs, such as batteries, pads and AED wall cabinets. In addition, the site offers the OxySure Model 615 emergency oxygen device to place as a companion product next to an AED, as well as display wallboxes, resuscitation bags, pulse oximeters and other related medical items. Other features and benefits offered by the site include:
- Free shipping for orders shipped to all addresses in the contiguous USA
- Shipping to international destinations
- Acceptance of all credit cards and Paypal
- Secure shopping with SSL encryption
- Mobile friendly
The Company also announced a launch discount to the first 100 customers to purchase from the website. The discount is obtained by applying coupon code LAUNCH10 upon checkout.
Ross added: “This is the first in a series of steps we are executing relative to the implementation of our e-retail strategy. And our e-retail strategy complements our distribution and sales operations very well as they focus on developing offline solutions for our institutional customers. We are already working on our next stellar online property.”
According to Statistica.com the growth in online shopping will rocket in the next several years. In 2013, global e-retail sales amounted to 839.8 billion U.S. dollars and projections show a growth of up to 1.5 trillion U.S. dollars by 2018. The U.S. is currently the largest regional market for online shopping, with sales worth some 126 billion U.S. dollars reported in 2013, more than double the amount in 2008.
AED-Oxygen.com is a division of OxySure Therapeutics, Inc. (OXYS). AED-Oxygen is a premier online store focused on cardiac and respiratory medical safety and resuscitation equipment and supplies at highly competitive prices. The website offers all AED brands, including Philips, Cardiac Science, Physio Control, Defibtech, and HeartSine. In addition, customers can purchase OxySure Model 615 emergency oxygen device, OxySure cartridges, pulse oximeters, display wallboxes (including double wallboxes designed to house both an AED and an oxygen device), wall signage, batteries, pads, resuscitation bags, and many more. www.AED-Oxygen.com
About OxySure Therapeutics, Inc.
OxySure Therapeutics, Inc. (OTCQB: OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. In addition to oxygen products for public/lay responder usage, OxySure also markets emergency medical solutions including AEDs (Cardiac Science, Philips, Zoll, Physio Control, Defibtech, and HeartSine), Quickclot Bleeding Control solutions, resuscitation products and pulse oximetry products. www.OxySure.com
RB Milestone Group, LLC.
+1 (212) 661-0075
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Therapeutics, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Therapeutics, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2014.